Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone-Reference-Cited by-全球学者库

Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration-resistant prostate cancer patients treated with abiraterone

Published:2017-07-28 Issue:12 Volume:77 Page:1233-1241
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Fan Liancheng¹,Wang Xiao²,Chi Chenfei¹,Wang Yanqing¹,Cai Wen¹,Shao Xiaoguang¹,Xu Fan¹,Pan Jiahua¹,Zhu Yinjie¹,Shangguan Xun¹,Xin Zhixiang¹,Hu Jianian¹,Xie Shaowei¹,Wang Rui³,Zhou Lixin¹,Dong Baijun¹,Xue Wei¹^ORCID

Affiliation:

1. Department of Urology; Renji Hospital, School of Medicine; Shanghai Jiao Tong University; Shanghai China

2. State Key Laboratory of Oncogenes and Related Genes; Renji-Med X Clinical Stem Cell Research Center; RenJi Hospital; School of Medicine; Shanghai Jiao Tong University; Shanghai China

3. Department of Ultrasound in Medicine; Shanghai Jiaotong University Affiliated Sixth People's Hospital; Shanghai Institute of Ultrasound in Medicine; Shanghai China

Funder

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support

Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai

Shanghai Jiao Tong University School of Medicine

Incubating Program for clinical Research and Innovation of Renji Hospital Shanghai Jiao Tong University School of Medicine

Science and Technology Commission of Shanghai Municipality

Shanghai Municipal Education Commission

the Joint Research Foundation for Innovative Medical Technology of Shanghai Shenkang Hospital Development Center

Shanghai Municipal Population and Family Planning Commission

National Natural Science Foundation of China

Publisher

Wiley